The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A Multicenter, Open-label, Four-way Crossover Study of the Effects of Esomeprazole, Aspirin and Rofecoxib on Prostaglandin (PGE2) Production, Cyclooxygenase-2 Enzyme Activity and PCNA Expression in Patients with Barrett’s Esophagus
- collapse A Multicenter, Double-blind, Three-way Crossover Intraesophageal and Intragastric pH Study of Three Esomeprazole Treatment Regimens in Documented Barrett’s Esophagus Patients
- collapse Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates for Once Daily Treatment with Esomeprazole 20 mg and Lansoprazole 15 mg for 6 months in Patients whose EE Has Been Healed
- collapse Epidemiological study to assess the symptom patterns and management strategies in patients consulting with persistent GERD symptoms in Primary Care
- collapse A study to assess whether maintenance treatment with esomeprazole 20mg od is at least as effective as lansoprazole 30mg od in patients with reflux disease - A 3 month, randomised, double blind, double dummy, multicenter study
- collapse A open, six-way, crossover, randomised dose-response relationship study of esomeprazole 20, 40 and 80 mg and lansoprazole 15, 30 and 60 mg regarding 24-hour intragastric pH-recording following repetead oral dose administration in healthy subjects
- collapse An Open, Single-Centre, Randomized, 6-way Crossover, Dose-Response Comparative Study of Esomeprazole 20, 40 and 80 mg and Pantoprazole 20, 40 and 80 mg regarding 24-hour Intragastric pH following 5 Days Repeated Oral Dose Administration in Patients with Symptoms of Gastroesophageal Reflux Disease
- collapse A Phase III, Multicenter, Open-Label Study to Evaluate the Control of Gastric Acid Secretion with Esomeprazole in Patients with Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome for 6 Months
- collapse A histopathological evaluation of Helicobacter pylori eradication in patients treated in long-term compassionate use study with omeprazole (Losec). An open study using two antibiotics with omeprazole for seven days or omeprazole alone and with long-term follow up.
